Buscar resultados de ensayos clínicos
Antithrombin III Deficiency - 11 Studies Found
Estado | Estudiar |
Completed |
Nombre del estudio: Recombinant Human Antithrombin (rhAT) in Patients With Hereditary Antithrombin Deficiency Undergoing Surgery or Delivery Condición: Antithrombin III Deficiency Fecha: 2005-05-10 Intervenciones: Biological: Recombinant human antithrombin (rhAT) Up to 24 hours prior to the scheduled elective surgica |
Recruiting |
Nombre del estudio: Safety, Pharmacokinetics and Efficacy of an AT-III Concentrate. Condición: Antithrombin III Deficiency Fecha: 2006-04-26 Intervenciones: Drug: Plasma-derived AT-III concentrate Segment I: A singl |
Recruiting |
Nombre del estudio: Atenativ Effect on Uterine Blood Flow and Preeclampsia Condición: Antithrombin III Deficiency Fecha: 2014-10-28 Intervenciones: Drug: Atenativ intravenous transfusion Other Name: a |
Completed |
Nombre del estudio: A Study of KW-3357 in Congenital Antithrombin Deficiency Condición: Congenital Antithrombin Deficiency Fecha: 2009-07-10 Intervenciones: Drug: KW-3357 50IU/mL, IV single dose |
Terminated |
Nombre del estudio: Response of Recombinant Antithrombin in Heparin Resistant Patients Undergoing Cardiac Surgery Condición: Thrombophilia Due to Acquired Antithrombin III Deficiency Fecha: 2012-02-07 Intervenciones: Drug: Recombinant antithrombin (rhAT) Subjects will receive an intravenous bolus of 500 units of recombi |
Completed |
Nombre del estudio: Use of Antithrombin in Cardiac Surgery With Cardiopulmonary Bypass Condición:
Intervenciones: Drug: Antithrombin III Single dose of antithrombin III sufficient to achieve a preoperative level of 120 |
Completed |
Nombre del estudio: Anti-thrombin III (ATIII) vs Placebo in Children (<7mo) Undergoing Open Congenital Cardiac Surgery Condición: ATIII Deficiency Fecha: 2014-04-01 Intervenciones:
|
Completed |
Nombre del estudio: Assess Incidence of Deep Vein Thrombosis(DVT)Following Administration of Recombinant Human Antithrombin (rhAT) to Hereditary Antithrombin(AT) Deficient Patients in High Risk Situations. Condición: Antithrombin Deficiency, Congenital Fecha: 2003-03-17 Intervenciones: Biological: Recombinant Human Antithrombin (rhAT) Biological/Vaccine: Recombinant human antithrombin(rhA |
Not yet recruiting |
Nombre del estudio: Response of Continuous Recombinant Antithrombin Infusion in Postcardiotomy ECMO Patients Condición: Antithrombin Deficiency Type 2 Fecha: 2017-03-21 Intervenciones: Drug: ATryn continuous infusion replenish serum thrombin levels |
Recruiting |
Nombre del estudio: "Incidence and Consequences of Disorders of Glycosylation in Patients With Conotruncal and Septal Heart Defects" Condición:
|